CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts Abstract Library LiverQ Academy National Conference
 
Back Industry  
 
Available Topics
03-01-2019 Model finds bariatric surgery cost-effective in NASH
04-05-2016 FDA staff finds Intercept's liver drug effective as monotherapy
11-21-2014 Most heavy drinkers are not alcoholics, U.S. study finds
09-17-2014 Study shows downward trend in Sovaldi utilization
09-15-2014 Gilead to raise price for new hepatitis C drug above $84,000
08-13-2014 Vertex to end sales of hepatitis C drug telaprevir (Incivek)
06-20-2014 A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi
05-01-2014 WellPoint's Obamacare business making a profit, so far
04-17-2014 UnitedHealth: New hepatitis C drug costs far more than forecast
04-10-2014 U.S. drug industry group defends price of Gilead hepatitis drug
03-21-2014 Gilead offers Egypt new hepatitis C drug at 99 percent discount
03-04-2014 Big Pharma pushes for U.S. action against India over patents
 
 
 
 

HEPATITIS

HBV
HCV
HDV

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Webcasts
Slide Library
Abstract Library

CHOLESTATIC

PBC

HCC

Slide Library
Abstract Library

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Mission Statement
Board of Trustees
Embassy of Education
Board of Advisors/Faculty
2022 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.